| ||||||||||||||
|
|
|||||||||||||
Department of Intensive Care Medicine, Henry Dunant General Hospital; and Evangelismos General Hospital, Athens, Greece
Address correspondence and reprint requests to Spyros D. Mentzelopoulos, MD, DEAA, 12 Ioustinianou St., 11473 Athens, Greece. Address e-mail to sdm{at}hol.gr
| Abstract |
|---|
|
|
|---|
IMPLICATIONS: By assessing respiratory mechanics, inspiratory work, hemodynamics, and gas exchange, we showed that prone positioning of mechanically ventilated chronic obstructed pulmonary disease patients improves oxygenation and lung mechanics during sigh versus semirecumbent positioning. Furthermore, certain pronation-related benefits versus preprone-supine positioning (reduced lung elastance and improved oxygenation) are maintained in the postprone supine position.
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
|
30 mm Hg. During the 4.5- to 5-h study period, patient care was provided by a physician uninvolved in the study. Any new or additional administration of IV fluid boluses, inotropes, antipyretics, vasodilators, antiarrhythmic treatment, diuretics, insulin, or bronchodilators would cause patient exclusion. Electrocardiographic lead II, peripheral intraarterial, and pulmonary artery (Hands off® Infusion Port Thermodilution Catheter, Arrow, Reading, PA) pressures, urinary bladder temperature (Mon-a-thermTM Foley-TempTM, Mallinckrodt, St Louis, MO), and peripheral O2 saturation (SO2) were monitored continuously. After replacement of any enteral nutrition by a parenteral of identical nutrient-composition and administration rate (with subsequent propofol infusion-related lipid intake taken into account), gastric contents evacuation by suction, nasogastric tube removal, and hydroxyethyl starch administration (35 mL/kg), patients were placed in a baseline supine (supineBAS) position (90 degree inclination). Anesthesia and neuromuscular blockade were induced and maintained throughout the study period with propofol-fentanyl and cisatracurium, respectively. Full train-of-four inhibition (facial nerve stimulation) was always accomplished. Baseline ventilator settings (volume control mode) were: tidal volume (VT) of 0.6 ± 0.02 L; breaths/min, 18.0 ± 0.7; inspiratory time-to-total respiratory cycle length ratio, 0.20 ± 0.01; inspiratory flow (V/s), 0.91 ± 0.02 L/s; plateau pressure time, 0 s; positive end-expiratory pressure (PEEP), 0 cm H2O; and FIO2, 0.6.
V/s was measured with a heated pneumotachograph and a differential pressure transducer, and VT was obtained by V/s-signal integration (6). Tracheal pressure (Paw) was measured with a 1.5-mm ID, 50-cm long catheter placed 23 cm past the ETT-tip and a pressure transducer (6). Esophageal pressure (Pes) and gastric pressure (Pga) were measured with a thin-walled latex double balloon-catheter system (6); proximal and distal balloons were placed in the mid-esophagus and stomach and inflated with 0.5 and 1.0 mL of air, respectively. Each balloon-catheter was proximally connected to a pressure transducer (6). Correct esophageal balloon placement was verified just before the cisatracurium administration by occlusion test (7). Paw-Pes difference yielded transpulmonary pressure (PL). After analog-to-digital conversion (sample rate, 200 Hz), variable-data were stored on IBM-type computer hard disk for later-on-analysis with a dedicated program (2). Breathing circuit modifications were as previously described (6).
Respiratory mechanics were assessed with constant V/s rapid airway occlusion (6) in the supineBAS, protocol supine (supinePROT), semirecumbent (45 degree inclination), and prone positions. The latter three postures order was randomized a priori for all 10 patients with the Research Randomizer (http://www.randomizer.org/form.htm). Patients remained in each posture for 6575 min. Supine-to-prone and prone-to-supine turning were performed by six attendants with an ETT and pressure-measuring devices manually immobilized and temporarily disconnected from breathing circuit (for
20 s) and pressure transducers, respectively. After patient turning, ETT displacement was excluded by capnography, breath sound-auscultation, and unchanged insertion length-confirmation (used also for exclusion of pressure-measuring devices displacement). After pronation, abdominal movement-restriction was minimized (2).
Apart from nonbaseline test breaths, described later, only previously described baseline ventilation was used. In supineBAS position, a pair of test breaths (VT, 0.6 L [baseline]; square-wave V/s, 0.91 L/s) were administered within 4555 min after neuromuscular blockade institution. Within 4565 min after assumption of each studied posture, test breaths with constant, square-wave V/s (0.91 L/s) and VT randomly varied from baseline to 0.2, 0.4, 0.8, 1.0, and 1.2 (sigh) L were administered twice. Test breaths were separated by brief baseline ventilation periods (Fig. 1) (6).
|
Baseline-ventilation PEEPi,rs was measured as the Paw-plateau during the test breath preceding
2-s end-expiratory occlusion (EEO) referred to atmospheric pressure (Fig. 1). PEEPi,L, PEEPi,cw, and abdominal cw-component (PEEPi,ab-cw) were measured as respective EEO-plateau pressures referred to their preocclusion values (8). PEEPi,ab-cw was always approximately zero. End-expiratory lung volume (EELV)-change (
EELV) was measured as previously described (6).
EEO was followed by 4 to 5-s end-inspiratory occlusion (EIO), enabling determination of maximal pressure (Pmax), pressure immediately after EIO-initiation (P1), and plateau pressure (P2) during Paw-Pes computer-stored-data display, and of Pmax and P2 during Pga computer-stored-data display (Fig. 1). In accordance with PEEPi determinations, Paw values were referred to atmospheric pressure, whereas Pes-Pga values were referred to their pre-EEO values (6,8). During EIO, Paw was unaffected by gas exchange (6).
1.2-L-VT test breaths were used as sigh breaths, which constitute effective recruitment maneuvers (3); other recruitment maneuvers were not used. According to randomized posture sequence, pronation was used immediately after supineBAS in three patients, to whom pre-prone sigh breaths were not administered. Sigh breaths were to be discontinued if P2aw exceeded 45 cm H2O (9). High FIO2 was selected because of possible participation of nonresponders to pronation (10) and to minimize hypoxemia-risk during
EELV determinations and hemodynamic measurements. Any pronation-induced hypoxemia (SO2
90%) would result in protocol termination and body posture-ventilatory variable change.
In each posture, intravascular-pressure transducers (Abbott, Sligo, Ireland) were zeroed at right atrial level. Within 3045 min after posture assumption, thermodilution cardiac output (CO), central venous pressure (CVP), and pulmonary artery wedge pressure (PAWP) were determined three times consecutively during respective 30 to 45-s ETT disconnections from breathing circuit. ETT disconnections were initiated at end-inspiration and separated by two 5-min-lasting baseline ventilation intervals. Accordingly, heart rate and mean arterial blood pressure and MPAP values were averaged over each ETT-disconnection period. Just before each ETT disconnection, mixed venous and arterial blood gas (BG) samples were taken and analyzed immediately (ABL System 625; Radiometer, Copenhagen, Denmark). There were no appreciable differences among initial, second, and third BG values. Thus, BG analyses corresponded to baseline ventilation conditions. BG temperature corrections were not performed. Only BG analysis-derived SO2 values were analyzed. Formula-derived variables included cardiac, systemic and pulmonary vascular resistance index, O2 consumption (
O2), respiratory quotient (R), alveolar PO2, and shunt fraction (QS/QT) (Appendix I). For each posture, only means of variable value-sets were analyzed.
V/s, VT, Paw, Pes, and Pga values of test breath-pairs were stored and averaged in Microsoft Excel 2000. The following variable sets were determined at baseline and sigh VT: (a) maximal (Rmax), ohmic (Rmin), and additional (
R) rs-component resistances (defined as corresponding Pmax-P2, Pmax-P1, and P1-P2 differences divided by preceding V/s, respectively) and (b) dynamic (Edyn), static (Estat), and additional (
E) rs-component elastances (defined as corresponding P1-PEEPi, P2-PEEPi, and P1-P2 differences divided by preceding VT, respectively). For the three protocol postures, pressure-volume curves were constructed, and total (Wtot), resistive, additional dynamic, elastic, and PEEPi inspiratory work per breath performed on each rs component were determined by respective surface area measurement in Autocad 2000 (Autodesk, San Rafael, CA) (Figs. 2A and B).
|
|
|
| Results |
|---|
|
|
|---|
At baseline VT, prone positioning resulted in (a) higher Edyn,cw and Estat,cw versus all other postures (all P < 0.01), and (b) higher
R,rs,
E,rs,
R,cw, and
E,cw and lower Estat,L versus supineBAS and supinePROT (P < 0.050.01); semirecumbent positioning resulted in higher Rmax,rs,
R,rs,
E,rs
R,cw, Edyn,cw, and
E,cw versus supineBAS and supinePROT (all P < 0.01) (Table 2; Figs. 3A,B,E,F). At sigh VT, prone positioning resulted in (a) lower Rmax,rs,
R,rs,
E,rs,
R,L, and
E,L and higher Edyn,cw and Estat,cw versus supinePROT and semirecumbent (P < 0.050.01), (b) higher Rmin,cw versus semirecumbent (P < 0.01), and (c) lower Estat,L versus supinePROT (P < 0.05). Inspiratory work comparison-results were consistent with our results on elastance, resistance, and PEEPi (Appendix II; Figs. 2C and D). Wtot,rs, which reflected total rs-impedance to mechanical breathing while VT increased from 0.2 L to sigh (Appendix II; Fig. 2A), was unaffected by posture change (Figs. 2C and D).
|
EELV (0.41* ± 0.08 L),
Pmax,ga at baseline and sigh VT (3.8* ± 1.0 and 6.3* ± 3.6 cm H2O, respectively), and
P2,ga at baseline and sigh VT (3.4* ± 0.8 and 4.9* ± 3.8 cm H2O, respectively). Thus, body posture did not affect dynamic hyperinflation (6), Rmax,ab-cw, and Estat,ab-cw. Pga at rs relaxation volume (Vr) (11.1* ± 4.9 cm H2O) was also unaffected by posture change, suggesting lack of prone position-related abdominal compression. Pes at EELV (pre-EEO value) and Vr were lower in prone versus supineBAS and supinePROT positions (10.7 ± 2.1 and 6.1 ± 1.5 versus 17.8 ± 3.5 and 16.9 ± 3.0 and 13.3 ± 4.0 and 10.6 ± 1.8 cm H2O, respectively; all P < 0.05), indicating lack of comparability of absolute Pes-measurements. Pes at EELV exceeded Pes at Vr in all postures (all P < 0.05 by paired t-test). By selecting the larger of these two expiratory Pes-values as reference (see Methods), we eliminated the effect of their posture-related variability on our determinations of test breath-induced changes in Pes (8).
During EIO, mean maximal amplitude of cardiac oscillations in Pes (Fig. 1) was similar in all postures (1.4* ± 0.6 cm H2O), indicating similar magnitude of transmitted intracardiac pressure-changes to the esophageal balloon. During EIO-oscillations, mean Pes-increase rate (Fig. 1) was also stable (9.0* ± 3.2 cm H2O/s) in all postures.
Posture changes did not affect hemodynamic variables. In contrast, pronation resulted in (a) higher PaO2 and lower QS/QT versus all other postures (P < 0.050.01) and (b) lower PaCO2 and mixed venous PCO2 (PvCO2) versus supineBAS and supinePROT (all P < 0.01) (Table 3; Figs. 3C and D).
During study period, there were no appreciable changes in energy expenditure or metabolic rate determinants such as physiologic stress level (clinical stability was maintained), patient-temperature (37.3* ± 0.4, maximal fluctuation always
0.6°C), feeding, and medication. Also, formula-derived
O2 was stable and calculated R constant; thus, CO2 production should also be stable. During study period, CO was stable, indicating unchanged CO2-delivery rate to the Ls and time available for alveolar-capillary gas equilibration. Consequently, in each posture, mixed venous-to-arterial CO2 concentration difference (Cv-aCO2) reflected L-CO2 elimination efficiency. Because CCO2-PCO2 relationship was almost linear at rest and its determinants (pH, HCO3, hemoglobin concentration, and SO2) (11) were unaffected by posture change, similar PCO2 changes reflected similar CCO2 changes in all postures. Furthermore, in each posture, mixed venous-to-arterial PCO2 difference (Pv-aCO2) reflected L-CO2 elimination efficiency in that particular posture (12). However, as L-CO2 excretion also depends on PvCO2 per se (12), we expressed its efficiency as fractional PvCO2 change after the blood passes through the pulmonary circulation (Pv-aCO2/PvCO2). Pv-aCO2 and PvCO2 were higher in prone position versus supineBAS and supinePROT (both P < 0.01).
Random posture sequence resulted in five patients being repositioned supine after pronation (Table 4; Fig. 4). Regarding cw mechanics, prone versus supineBAS and supinePOSTPRO differences were as previously described (Tables 2 and 4; Figs. 3A and B, 4A and B ); however, Estat,L was lower only versus supineBAS (P < 0.01). Accordingly, supinePOSTPRO versus supineBAS resulted in lower Estat,rs and Estat,L (P < 0.050.01). Regarding CO2, prone versus supineBAS and supinePOSTPRO differences were as previously described (Tables 3 and 4; Figs. 3C and D, 4C and D HREF="#FIG4">). However, QS/QT was similar in the prone position and supinePOSTPRO. Accordingly, supinePOSTPRO versus supineBAS resulted in lower QS/QT and higher PaO2 (P < 0.050.01). By contrast, in the five patients in whom supinePROT preceded pronation (supinePREPRO), all supineBAS and supinePREPRO versus prone differences in rs mechanics and gas exchange were as above for the whole patient group (data not shown).
|
|
| Discussion |
|---|
|
|
|---|
We showed that semirecumbent positioning merely increases thoracic-tissue viscoelastic resistance versus supine at baseline VT (Appendix II; Tables 2 and 3; Figs. 2C and D, 3A); nevertheless, its major benefit versus supine is reduction of nosocomial pneumonia risk (13). In contrast, pronation augments ventilation-perfusion (V/Q) matching and CO2 elimination versus supine; probable contributory factors include increased ribcage elastance (2) and elimination of L-compression by the heart (14), resulting in decreased Estat,L, attenuated L-inflation gradient, and more homogenous regional and increased total effective alveolar ventilation (VALV) versus supine (2,14). Pronation proved superior versus semirecumbent with respect to V/Q matching but not CO2 elimination; this is consistent with the cw/L mechanics similarities in semirecumbent and supine positions but suggests a slightly increased effective VALV in the former.
In supinePOSTPRO, CO2 elimination decreased toward baseline (Table 4, Figs. 4C and D), indicating accentuated L-inflation gradient versus prone, causing a decrease in effective VALV; accordingly, cw mechanics were similar versus supineBAS; however, arterial oxygenation and QS/QT were still improved versus supineBAS (Table 4, Figs. 4C and D), indicating partial maintenance of pronations augmented VALV homogeneity and V/Q matching; this is consistent with enhanced dorsal L-region recruitment during tidal L-inflation versus supineBAS because of the preceding pronation effects (2).
Some may argue that our results on pronation were mainly because of posture change-induced mobilization of tracheobronchial secretions. However, this cannot explain the partial reversal of pronation benefits in supinePOSTPRO because they should be further enhanced by further secretion mobilization secondary to further posture change.
The pronation-induced reduction in L-time constant inequality during sigh-VT EIO (Appendix II; Table 2; Figs. 2D, 3E and F) suggests a reduced number of L-units with very low (tending toward 0) or high (tending toward infinity) time constants and, thus, a reduced number of atelectatic and hyperinflated alveoli, respectively; this further suggests increased sigh effectiveness and reduced alveolar-rupture probability. Furthermore, the observed hemodynamic and ventilation-conditions stability and absence of posture-shift-related complications in conjunction with the rest of our results demonstrate prone positions applicability, effectiveness, and benefits versus semirecumbent positioning.
Posture sequence randomization enabled posture-data determinations and comparisons without risk of a certain posture order systematically influencing results obtained in a subsequent one. Data on a postsemirecumbent supine position were not obtained for comparison with our postprone data; however, available and presented data (Table 2; Fig. 3) strongly suggest lack of semirecumbent-related benefit after supine posture resumption. Consequently, our methodology has enabled us to produce results leading to satisfactory conclusions regarding pronation merits.
Pes-measurements reliability could be questionable because after pronation, alveolar pressure transmission to the esophagus may vary as the heart moves ventrally (2). A change in heart positioning relative to the esophagus or esophageal-balloon should also affect transmission of intracardiac pressure changes to the latter. However, myocardial wall motion pattern, contractility, and cyclic intracardiac pressure changes should have remained stable in all postures (see Results; Table 3); consequently, our EIO-cardiac oscillation data suggest unchanged transmission pattern of intracardiac pressure changes to the esophageal balloon. Thus, the initial correct esophageal-balloon positioning relative to the heart was probably maintained throughout the study period, and respiratory cycle-induced Pes-changes were measured as accurately as possible in all postures (2,15).
A severe limitation was that no systematic data collection was planned in supinePOSTPRO position. This was counterbalanced by posture random order resulting in available-for-comparison supinePOSTPRO data in five participants. Because all determined variables exhibited similar response-patterns to posture change in all supinePOSTPRO-subset members, it is unlikely that the small size of the latter had significantly affected the results (16); this is also true for the whole study group. However, we cannot totally exclude type II errors (2).
EELV, physiologic and alveolar dead space and energy expenditure were not directly determined. The former two limitations were partially counterbalanced by our determinations of
EELV (increment in functional residual capacity because of expiratory flow limitation) (6) and Pv-aCO2/PvCO2 (which reflected effective VALV during hemodynamic and probable metabolic stability) (see Results). Finally, O2 measurements with metabolic monitors may exhibit inaccuracies at FIO2 >0.5 (17).
Noninvasive positive-pressure ventilation (NIPPV) is recommended as first-line treatment in ARF-COPD patients (1821). NIPPV may avert invasive mechanical ventilation (IMV) in 50%75% of cooperative, alert, hemodynamically stable patients (1821). However, a meta-analysis (22) revealed an overall NIPPV-induced IMV-reduction of only 18% in an ARF-COPD cohort, originating from 15 randomized-controlled trials (RCTs). Also, approximately 80% of ARF-COPD patients admitted to a university-affiliated intensive care unit required IMV (23). ARF-COPD patients exhibit an in-hospital mortality of 24% (24), which may be reduced by using lower VTs during IMV (and thus, decreasing the incidence of hemodynamic compromise and ventilator-induced lung injury [VILI]) (23). Interestingly, recent evidence suggests that intermittent pronation may also reduce VILI-risk (25). Our findings of pronation-induced improvement in L-mechanical behavior (Table 2; Figs. 3A,B,E,F) are consistent with reduced VILI risk; furthermore, we demonstrated a pronation-induced improvement in gas exchange efficiency (i.e., L-function) (Tables 2 and 3; Figs. 3C and D), partially maintained along with pronation Estat,L-reduction (improvement in L-mechanics) in supinePOSTPRO (Table 4; Figs. 4AD). Thus, pronation may constitute a useful therapeutic strategy in the management of ARF-COPD patients, and RCTs comparing outcomes of COPD patients treated with prone and semirecumbent positioning are warranted.
| Appendix I |
|---|
|
|
|---|
PaCO2. CO = cardiac output (L/min); BSA = body surface area (m2); MAP = mean arterial blood pressure (mm Hg); CVP = central venous pressure (mm Hg); CI = cardiac index (L · min-1 · m-2); 80 = transformation factor of Wood units (mm Hg · L-1 · min) to standard metric units (dynes · s · cm-5); MPAP = mean pulmonary artery blood pressure (mm Hg); PAWP, pulmonary artery wedge pressure (mm Hg); Hgb = hemoglobin concentration in g/L; 1.36 = O2 combining power of 1 g of hemoglobin (mL); SaO2 = arterial O2 saturation; SvO2 = mixed venous O2 saturation; FEY = fractional energy yield relative to total of pre-scribed nutritional support; P = gas partial pressure (mm Hg); PIO2 = inspired O2 partial pressure (mm Hg); PACO2 = alveolar CO2 partial pressure (mm Hg); FIO2 = inspired O2 fraction; R = respiratory quotient; PB = barometric pressure (mm Hg); 47 = water saturated vapor pressure at 37°C (mm Hg); 0.003 = O2 solubility coefficient at 37°C (mL · dL-1 · mm Hg); PO2 = O2 partial pressure (mm Hg); CcO2/CaO2/CvO2 = O2 content in end-capillary/arterial/mixed-venous blood (respectively).
| Appendix II |
|---|
|
|
|---|
R),4 caused by time constant inequality within the lung or tissue stress relaxation tension and static elastance (Estat) as tidal volume varies from 0.2 to 1.2 L (by 0.2 L increments) with square-wave inspiratory flow kept constant at 0.91 L/s (protocol test breathing (PTB) described in Methods).
R and
E during PTB.
| Footnotes |
|---|
2 Source: Reference 17. ![]()
3 Sources: Reference 6 and Eissa NT, Ranieri VM, Correil C, et al. Analysis of behavior of the respiratory system in ARDS patients: effects of flow, volume, and time. J Appl Physiol 1991;70:271929. ![]()
4 Related to additional elastance (
E) according to the following formula:
E =
R/inspiratory time. ![]()
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. A. Fiz, J. Gnitecki, S. S. Kraman, G. R. Wodicka, and H. Pasterkamp Effect of Body Position on Lung Sounds in Healthy Young Men Chest, March 1, 2008; 133(3): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mentzelopoulos, J. Sigala, C. Roussos, and S. G. Zakynthinos Static pressure-volume curves and body posture in severe chronic bronchitis Eur. Respir. J., July 1, 2006; 28(1): 165 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mentzelopoulos, M. Tzoufi, K. Rellos, A. S. Michalopoulos, E. Stamataki, C. Roussos, and S. G. Zakynthinos An Evaluation of McCoy Balloon Laryngoscopy in Patients With Moderate-to-Major Endotracheal Intubation Difficulty Anesth. Analg., October 1, 2005; 101(4): 1233 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tzoufi, S. D. Mentzelopoulos, C. Roussos, and A. Armaganidis The Effects of Nebulized Salbutamol, External Positive End-Expiratory Pressure, and Their Combination on Respiratory Mechanics, Hemodynamics, and Gas Exchange in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients Anesth. Analg., September 1, 2005; 101(3): 843 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mentzelopoulos, C. Roussos, and S. G. Zakynthinos Prone position reduces lung stress and strain in severe acute respiratory distress syndrome Eur. Respir. J., March 1, 2005; 25(3): 534 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mentzelopoulos, C. Roussos, and S. G. Zakynthinos Prone position improves expiratory airway mechanics in severe chronic bronchitis Eur. Respir. J., February 1, 2005; 25(2): 259 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guerin, S. Gaillard, S. Lemasson, L. Ayzac, R. Girard, P. Beuret, B. Palmier, Q. V. Le, M. Sirodot, S. Rosselli, et al. Effects of Systematic Prone Positioning in Hypoxemic Acute Respiratory Failure: A Randomized Controlled Trial JAMA, November 17, 2004; 292(19): 2379 - 2387. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||